{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:20:07Z","timestamp":1791192007023,"version":"4.1.0"},"reference-count":62,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            The objective of the study was to measure antiretroviral exposures in four physiological compartments during pregnancy, delivery, and postpartum. This prospective, open-label, longitudinal study collected paired blood plasma (BP) and genital tract (GT) aspirates antepartum, at delivery, and up to 12 weeks postpartum. Antiretroviral cord BP and amniotic fluid concentrations were also measured. Drug concentrations were analyzed by validated high-performance liquid chromatography\/UV and liquid chromatography\/tandem mass spectrometry methods, with secondary compartment concentrations presented as the percentage of BP. Fourteen women taking lamivudine plus zidovudine and either lopinavir-ritonavir (\n            <jats:italic>n<\/jats:italic>\n            = 7), nelfinavir (\n            <jats:italic>n<\/jats:italic>\n            = 6), or nevirapine (\n            <jats:italic>n<\/jats:italic>\n            = 1) were enrolled; four also received tenofovir. GT penetration relative to BP was highest for the nucleoside reverse transcriptase inhibitors compared to the protease inhibitors and nevirapine. Only antepartum nelfinavir GT penetration was significantly higher than in the second trimester (geometric mean ratio [GMR], 179.3) or third trimester (GMR, 41.9). Compared to nonpregnant historical controls, antepartum GT penetration was significantly lower (\n            <jats:italic>P<\/jats:italic>\n            &lt; 0.05) for zidovudine (GMR, 0.25) and lopinavir (GMR, 0.03); postpartum lopinavir GT penetration continued to be significantly lower (GMR, 0.27). Cord BP exposures were highest for lamivudine and tenofovir (\u2265100%), with cord BP levels of the remaining drugs ranging from 49 to 86% of that of the respective BP level. Amniotic exposures for lamivudine, zidovudine, tenofovir, and nelfinavir were \u2265100%, nevirapine exposure was 53%, and lopinavir and ritonavir exposures were \u22646% that of BP. We conclude that GT, cord BP, and amniotic fluid exposures vary within and between antiretroviral drug classes and biologic sites. Measurement of antiretroviral exposure in maternal genital secretions, cord BP, and amniotic fluid may be needed to identify signals of subtherapeutic or supratherapeutic drug exposure.\n          <\/jats:p>","DOI":"10.1128\/aac.01523-08","type":"journal-article","created":{"date-parts":[[2009,3,24]],"date-time":"2009-03-24T01:39:47Z","timestamp":1237858787000},"page":"2367-2374","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":55,"title":["Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women"],"prefix":"10.1128","volume":"53","author":[{"given":"Rosa F.","family":"Yeh","sequence":"first","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser L.","family":"Rezk","sequence":"additional","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D. M.","family":"Kashuba","sequence":"additional","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie B.","family":"Dumond","sequence":"additional","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba L.","family":"Tappouni","sequence":"additional","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chuan","family":"Tien","sequence":"additional","affiliation":[{"name":"FPG Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Chi","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoli","family":"Vourvahis","sequence":"additional","affiliation":[{"name":"School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Horton","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Fiscus","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine B.","family":"Patterson","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11908-008-0082-z","volume":"10","year":"2008","unstructured":"Anderson, B. L., and S. Cu-Uvin. 2008. Determinants of HIV shedding in the lower genital tract of women. Curr. Infect. Dis. Rep.10:505-511.","journal-title":"Curr. Infect. Dis. Rep."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200102160-00017"},{"key":"e_1_3_2_4_2","unstructured":"Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. 2008"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/QAI.0b013e31817bbe80","volume":"48","year":"2008","unstructured":"Bardeguez, A. D., J. C. Lindsey, M. Shannon, R. E. Tuomala, S. E. Cohn, E. Smith, A. Stek, S. Buschur, A. Cotter, L. Bettica, and J. S. Read. 2008. Adherence to antiretrovirals among US women during and after pregnancy. J. Acquired Immune Defic. Syndr.48:408-417.","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00002030-200003310-00006","volume":"14","year":"2000","unstructured":"Bhadrakom, C., R. J. Simonds, J. V. Mei, S. Asavapiriyanont, V. Sangtaweesin, N. Vanprapar, K. H. Moore, N. L. Young, W. H. Hannon, T. D. Mastro, N. Shaffer, et al. 2000. Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. AIDS.14:509-516.","journal-title":"AIDS."},{"key":"e_1_3_2_7_2","unstructured":"14th Conf. Retrovir. Opportunistic Infect. 2007"},{"key":"e_1_3_2_8_2","unstructured":"7th Conf. Retrovir. Opportunistic Infect. 2000"},{"key":"e_1_3_2_9_2","unstructured":"14th Conf. Retrovir. Opportunistic Infect. 2007"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1001\/archfami.5.5.297","volume":"5","year":"1996","unstructured":"Burney, K. D., K. Krishnan, M. T. Ruffin, D. Zhang, and D. E. Brenner. 1996. Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch. Fam. Med.5:297-300.","journal-title":"Arch. Fam. Med."},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4332-4336.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.01.034"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.2006.02628.x","volume":"62","year":"2006","unstructured":"Chen, Y. C., S. K. Gotzkowsky, A. N. Nafziger, R. W. Kulawy, M. L. Rocci, Jr., J. S. Bertino, Jr., and A. D. Kashuba. 2006. Poor correlation between 6\u03b2-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity. Br. J. Clin. Pharmacol.62:187-195.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.steroids.2003.10.004","volume":"69","year":"2004","unstructured":"Chen, Z., L. A. Dunning, K. E. Anderson, J. L. Holtzman, and W. Zheng. 2004. Within-person variability of urinary 6\u03b2-hydroxycortisol to urinaryl ratios in Caucasian women. Steroids69:67-70.","journal-title":"Steroids"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-146-8-200704170-00010"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311801"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00042560-200204150-00009","volume":"29","year":"2002","unstructured":"Cooper, E. R., M. Charurat, L. Mofenson, I. C. Hanson, J. Pitt, C. Diaz, K. Hayani, E. Handelsman, V. Smeriglio, R. Hoff, and W. Blattner. 2002. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J. Acquired Immune Defic. Syndr.29:484-494.","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00126334-200303010-00007","volume":"32","year":"2003","unstructured":"Droste, J. A., R. E. Aarnoutse, P. P. Koopmans, Y. A. Hekster, and D. M. Burger. 2003. Evaluation of antiretroviral drug measurements by an interlaboratory quality control program. J. Acquired Immune Defic. Syndr.32:287-291.","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328270385a"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.3.4.557"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.ftd.0000211817.58052.b8","volume":"28","year":"2006","unstructured":"Holland, D. T., R. DiFrancesco, J. D. Connor, and G. D. Morse. 2006. Quality assurance program for pharmacokinetic assay of antiretrovirals. ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring. Ther. Drug Monit.28:367-374.","journal-title":"Ther. Drug Monit."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejogrb.2004.05.016","volume":"117","year":"2004","unstructured":"Iversen, A. K., J. Attermann, J. Gerstoft, L. Fugger, J. I. Mullins, and P. Skinhoj. 2004. Longitudinal and cross-sectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract. Eur. J. Obstet. Gynecol. Reprod. Biol.117:227-235.","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.865"},{"key":"e_1_3_2_24_2","unstructured":"13th Confer. Retrovir. Opportunistic Infect. 2006"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100269"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305230-00011"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(06)70629-6"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-134-10-200105150-00011","volume":"134","year":"2001","unstructured":"Liu, H., C. E. Golin, L. G. Miller, R. D. Hays, C. K. Beck, S. Sanandaji, J. Christian, T. Maldonado, D. Duran, A. H. Kaplan, and N. S. Wenger. 2001. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann. Intern. Med.134:968-977.","journal-title":"Ann. Intern. Med."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.qai.0000245888.97003.a3","volume":"43","year":"2006","unstructured":"Liu, H., L. G. Miller, R. D. Hays, G. Wagner, C. E. Golin, W. Hu, K. Kahn, R. Haubrich, A. H. Kaplan, and N. S. Wenger. 2006. A practical method to calibrate self-reported adherence to antiretroviral therapy. J. Acquired Immune Defic. Syndr.43(Suppl. 1):S104-S112.","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/426595","volume":"40","year":"2005","unstructured":"Maggiolo, F., L. Ravasio, D. Ripamonti, G. Gregis, G. Quinzan, C. Arici, M. Airoldi, and F. Suter. 2005. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin. Infect. Dis.40:158-163.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1067\/mob.2001.108344","volume":"184","year":"2001","unstructured":"Mandelbrot, L., G. Peytavin, G. Firtion, and R. Farinotti. 2001. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus-infected pregnant women. Am. J. Obstet. Gynecol.184:153-158.","journal-title":"Am. J. Obstet. Gynecol."},{"key":"e_1_3_2_32_2","unstructured":"11th Eur. AIDS Conf. 2007"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200204120-00008"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/014572179502100109","volume":"21","year":"1995","unstructured":"Mason, B. J., J. R. Matsuyama, and S. G. Jue. 1995. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ.21:52-57.","journal-title":"Diabetes Educ."},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/00126334-200412150-00008","volume":"37","year":"2004","unstructured":"Min, S. S., A. H. Corbett, N. Rezk, S. Cu-Uvin, S. A. Fiscus, L. Petch, M. S. Cohen, and A. D. Kashuba. 2004. Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentrations in the genital tract of HIV-1-infected women. J. Acquired Immune Defic. Syndr.37:1577-1580.","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/00006454-200209000-00010","volume":"21","year":"2002","unstructured":"Mirochnick, M., A. Dorenbaum, D. Holland, B. Cunningham-Schrader, C. Cunningham, R. Gelber, L. Mofenson, M. Culnane, J. Connor, and J. L. Sullivan. 2002. Concentrations of protease inhibitors in cord blood after in utero exposure. Pediatr. Infect. Dis. J.21:835-838.","journal-title":"Pediatr. Infect. Dis. J."},{"key":"e_1_3_2_37_2","unstructured":"13th Conf. Retrovir. Opportunistic Infect. 2006"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1089\/aid.2007.0107","volume":"23","year":"2007","unstructured":"Molina, J. M., T. J. Podsadecki, M. A. Johnson, A. Wilkin, P. Domingo, R. Myers, J. M. Hairrell, R. A. Rode, M. S. King, and G. J. Hanna. 2007. A lopinavir\/ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks. AIDS Res. Hum. Retrovir.23:1505-1514.","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/314431"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1086\/501458"},{"key":"e_1_3_2_41_2","first-page":"814","volume":"4","year":"1990","unstructured":"Ohkita, C., and M. Goto. 1990. Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction. DICP24:814-816.","journal-title":"DICP"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.2.437-443.2004"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00251-06"},{"key":"e_1_3_2_44_2","unstructured":"14th Conf. Retrovir. Opportunistic Infect. 2007"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1086\/344311"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jchromb.2005.06.019","volume":"822","year":"2005","unstructured":"Rezk, N. L., R. D. Crutchley, and A. D. Kashuba. 2005. Simultaneous quantification of emtricitabine and tenofovir in human plasma using high-performance liquid chromatography after solid phase extraction. J. Chromatogr. B822:201-208.","journal-title":"J. Chromatogr. B"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200608000-00006"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1570-0232(03)00224-1","volume":"791","year":"2003","unstructured":"Rezk, N. L., R. R. Tidwell, and A. D. Kashuba. 2003. Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B791:137-147.","journal-title":"J. Chromatogr. B"},{"key":"e_1_3_2_49_2","unstructured":"13th Conf. Retrovir. Opportunisitic Infect. 2006"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1086\/315679"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000247114.43714.90"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","volume":"10","year":"2000","unstructured":"Streetman, D. S., J. S. Bertino, Jr., and A. N. Nafziger. 2000. Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics10:187-216.","journal-title":"Pharmacogenetics"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443080-00001"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.08.030"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1086\/367706"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.08.011"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2125.2006.02669.x","volume":"62","year":"2006","unstructured":"Villani, P., M. Floridia, M. F. Pirillo, M. Cusato, E. Tamburrini, A. F. Cavaliere, G. Guaraldi, C. Vanzini, A. Molinari, A. Degli Antoni, and M. Regazzi. 2006. Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women. Br. J. Clin. Pharmacol.62:309-315.","journal-title":"Br. J. Clin. Pharmacol."},{"key":"e_1_3_2_58_2","unstructured":"13th Conf. Retrovir. Opportunistic Infect. 2006"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012354"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/infdis\/163.2.226","volume":"163","year":"1991","unstructured":"Watts, D. H., Z. A. Brown, T. Tartaglione, S. K. Burchett, K. Opheim, R. Coombs, and L. Corey. 1991. Pharmacokinetic disposition of zidovudine during pregnancy. J. Infect. Dis.163:226-232.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.106.012765","volume":"35","year":"2007","unstructured":"Weiss, J., D. Theile, N. Ketabi-Kiyanvash, H. Lindenmaier, and W. E. Haefeli. 2007. Inhibition of MRP1\/ABCC1, MRP2\/ABCC2, and MRP3\/ABCC3 by nucleoside, nucleotide, and nonnucleoside reverse transcriptase inhibitors. Drug Metab. Dispos.35:340-344.","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002280100313","volume":"57","year":"2001","unstructured":"Yasui-Furukori, N., T. Kondo, T. Kubota, H. Otake, T. Ohkubo, T. Nagasaki, K. Sugawara, K. Chiba, K. Otani, and S. Kaneko. 2001. No correlations between the urinary ratio of 6\u03b2-hydroxycortisol to free cortisol and pharmacokinetics of alprazolam. Eur. J. Clin. Pharmacol.57:285-288.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"e_1_3_2_63_2","unstructured":"Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother. 2006"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01523-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01523-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T23:19:45Z","timestamp":1645485585000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01523-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1128\/AAC.01523-08"],"URL":"https:\/\/doi.org\/10.1128\/aac.01523-08","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]},"assertion":[{"value":"2008-11-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-03-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}